Testicular Cancer in the News
Colin Egglesfield Waited. He Wants You to Know That Almost Cost Him Everything.
Colin Egglesfield has faced three cancer diagnoses since 2006 — starting with a testicular cancer he waited too long to address. His story isn't about inspiration. It's about what delayed action actually costs, and why early detection is the only thing that changes the outcome.
A Blood Test That Could Change How Doctors Predict Recurrence
Researchers are studying a blood test targeting miR-371a-3p, a microRNA biomarker that may improve how doctors predict testicular cancer recurrence after treatment. Early results from the CLIMATE study show strong potential, but the test is not yet part of standard surveillance guidelines.